Slides
Page 1
Global Leader in Relapsed / Refractory AL Amyloidosis ASH This presentation contains clinical data presented at ASH Dec 7 , 2025 with a May 2026 update on pages 19-23 September 2026 :: IMMIX BIOPHARMA
Loading workspace
Global Leader in Relapsed / Refractory AL Amyloidosis ASH This presentation contains clinical data presented at ASH Dec 7 , 2025 with a May 2026 update on pages 19-23 September 2026 :: IMMIX BIOPHARMA
Your watchlist and earnings event details are available after you sign in.